Fireside Chat with Retina Experts and RetinAI: Clinical endpoints in dry AMD and GA today and where we might be headed in the future
Time: 4:20 pm
day: Day1
Details:
- Understanding the current state of clinical study endpoints that have been accepted by regulators
- Exploring the role of technology in validating structural endpoints
- Reviewing the promise for evaluating outer retinal layers, including other structural biomarkers as future clinical study endpoints
